(Q40529844)

English

Radiation dosimetry and first therapy results with a (124)I/ (131)I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy

scientific article published on 28 February 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

Radiation dosimetry and first therapy results with a (124)I/ (131)I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy (English)

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

Adaptive radiation therapy

0 references

Christian M. Zechmann

1

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

Ali Afshar-Oromieh

object named as

Ali Afshar-Oromieh

2

0 references

9

object named as

Jürgen Debus

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

Boris Hadaschik

object named as

Boris Hadaschik

6

0 references

5

object named as

Walter Mier

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

author name string

Tom Armor

3

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

James B Stubbs

4

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

John Joyal

7

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

Klaus Kopka

8

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

John W Babich

10

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

Uwe Haberkorn

11

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

publication date

28 February 2014

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

41

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

7

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

1280-1292

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

copyright license

Creative Commons Attribution 2.0 Generic

28 February 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1007/s00259-014-2713-y

0 references

Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052014

22 September 2017

Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052014

22 September 2017

Tyrosine kinase inhibitors: views of selectivity, sensitivity, and clinical performance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052014

22 September 2017

68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052014

22 September 2017

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052014

22 September 2017

Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052014

22 September 2017

Radioimmunotherapy of prostate cancer using 90Y- and 177Lu-labeled J591 monoclonal antibodies: effect of multiple treatments on myelotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052014

22 September 2017

Prediction of myelotoxicity based on bone marrow radiation-absorbed dose: radioimmunotherapy studies using 90Y- and 177Lu-labeled J591 antibodies specific for prostate-specific membrane antigen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052014

22 September 2017

Phase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052014

22 September 2017

Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052014

22 September 2017

Tolerance of normal tissue to therapeutic irradiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052014

22 September 2017

Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052014

25 September 2017

Toward prediction of efficacy of chemotherapy: a proof of concept study in lung cancer patients using [¹¹C]docetaxel and positron emission tomography.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052014

20 August 2018

First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052014

20 August 2018

A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052014

20 August 2018

Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052014

20 August 2018

Epidemiological trends and financial outcomes in radical prostatectomy among Medicare beneficiaries, 1991 to 1993.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4052014

20 August 2018

In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/24577951

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate-specific membrane antigen expression in normal and malignant human tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/24577951

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine

1 reference

https://pubmed.ncbi.nlm.nih.gov/24577951

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24577951

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-014-2713-Y

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40529844&oldid=1900017905"